The prevalence of Parkinson's disease in an Arab population, Wadi Ara, Israel
- PMID: 20450126
The prevalence of Parkinson's disease in an Arab population, Wadi Ara, Israel
Abstract
Background: The prevalence of Parkinson's disease varies among ethnic and geographic groups around the world, being very low in China and high in Argentina. While the main etiology of the disease has yet to be determined, environmental, occupational and genetic factors seem to play important roles.
Objectives: To estimate the prevalence of PD in an Arab Muslim population in Israel, using the drug tracer approach.
Methods: We studied a Muslim Arab population living in a well-defined geographic area in Israel, with the majority located in two towns and two large villages. Of the approximately 115,000 residents, about 38% are under the age of 15 and 7.75% are older than 65. Drug tracer methodology was applied in this study. All those who were on anti-PD medication were identified and examined by a neurologist to confirm the diagnosis.
Results: The overall crude prevalence of PD in this population was low, 43.24/100,000, while the prevalence in the age group above 65 years was 477.32/100,000. Below this age, the prevalence was very low, 12.29/100,000. PD prevalence was higher in males than in females (ratio 1.17); 63% of male patients smoked cigarettes. The prevalence was found to be twice as high among the residents of rural areas, where most inhabitants work in agriculture.
Conclusions: The prevalence of PD among the Arab population in Israel is considered low and comparable to that reported in other Arab countries.
Similar articles
-
[Prevalence of Parkinson disease in an urban area of the Ciudad de La Habana province, Cuba. Door-to-door population study].Neurologia. 2000 Aug-Sep;15(7):269-73. Neurologia. 2000. PMID: 11075574 Spanish.
-
Dynamics of parkinsonism-Parkinson's disease in residents of adjacent kibbutzim in Israel's Negev.Environ Res. 1997;73(1-2):156-61. doi: 10.1006/enrs.1997.3696. Environ Res. 1997. PMID: 9311541
-
Ethnic background as a risk factor for advanced age-related macular degeneration in Israel.Isr Med Assoc J. 2007 Sep;9(9):656-8. Isr Med Assoc J. 2007. PMID: 17939627
-
Parkinson's Disease in the Gulf Countries: An Updated Review.Eur Neurol. 2015;74(3-4):222-5. doi: 10.1159/000442283. Epub 2015 Nov 28. Eur Neurol. 2015. PMID: 26613525 Review.
-
Worldwide occurrence of Parkinson's disease: an updated review.Neuroepidemiology. 1993;12(4):195-208. doi: 10.1159/000110318. Neuroepidemiology. 1993. PMID: 8272179 Review.
Cited by
-
Parkinson's Disease Prevalence and Proximity to Agricultural Cultivated Fields.Parkinsons Dis. 2015;2015:576564. doi: 10.1155/2015/576564. Epub 2015 Aug 18. Parkinsons Dis. 2015. PMID: 26357584 Free PMC article.
-
Helicobacter suis Is Associated With Mortality in Parkinson's Disease.Front Med (Lausanne). 2019 Aug 28;6:188. doi: 10.3389/fmed.2019.00188. eCollection 2019. Front Med (Lausanne). 2019. PMID: 31555648 Free PMC article.
-
Variable PARK2 Mutations Cause Early-Onset Parkinson's Disease in a Small Restricted Population.J Mol Neurosci. 2017 Oct;63(2):216-222. doi: 10.1007/s12031-017-0972-3. Epub 2017 Sep 15. J Mol Neurosci. 2017. PMID: 28913705
-
Parkinson's Disease in the Middle East, North Africa, and South Asia: Consensus from the International Parkinson and Movement Disorder Society Task Force for the Middle East.J Parkinsons Dis. 2020;10(2):729-741. doi: 10.3233/JPD-191751. J Parkinsons Dis. 2020. PMID: 32176653 Free PMC article.
-
A synopsis on the role of tyrosine hydroxylase in Parkinson's disease.CNS Neurol Disord Drug Targets. 2012 Jun 1;11(4):395-409. doi: 10.2174/187152712800792785. CNS Neurol Disord Drug Targets. 2012. PMID: 22483313 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical